Public Company Healthcare

CareDx

Brisbane, California, United States

Precision medicine company focused on clinically differentiated diagnostic solutions and digital/transplant surveillance management for transplant patients and caregivers.

Focus Areas
Transplant diagnostics, Molecular diagnostics, Solid organ transplant surveillance
Website
caredx.com

Tracked deals

4

4 tracked deals across 2019-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

4 buyout

CareDx Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for CareDx. 2 2019 1 2023 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    CareDx, Inc.
    Target
    Naveris, Inc.
    Type
    Buyout

    CareDx entered into a definitive agreement to acquire Naveris, a commercial-stage precision oncology diagnostics company, for $160 million upfront cash plus up to $100 million in revenue-based milestones. The acquisition extends CareDx’s precision medicine testing strategy into specialty oncology via Naveris’ NavDx liquid biopsy platform for viral-mediated cancers and MRD surveillance, with an anticipated close in Q3 2026 subject to customary conditions.

  • Buyer
    CareDx, Inc.
    Target
    MediGO, Inc.
    Type
    Buyout

    CareDx, Inc. acquired MediGO, Inc., a provider of organ transplant supply-chain logistics software, to expand its digital health offerings for organ procurement organizations (OPOs) and strengthen pre-transplant capabilities. The acquisition is intended to accelerate operational efficiencies, increase organ utilization, and broaden CareDx's transplant ecosystem solutions.

  • Buyer
    CareDx, Inc.
    Target
    XynManagement
    Type
    Buyout

    CareDx, Inc. completed the acquisition of XynManagement, a provider of transplant quality-tracking software (XynQAPI) and waitlist management services. The deal adds pre-transplant patient outreach and analytics capabilities to CareDx's Digital Solutions portfolio and will integrate XynManagement products with CareDx offerings to expand patient reach and transplant analytics.

  • Buyer
    CareDx, Inc.
    Target
    OTTR Complete Transplant Management
    Type
    Buyout

    CareDx, Inc. agreed to acquire OTTR Complete Transplant Management, a provider of organ transplant patient-tracking software used by transplant centers in the US and Canada. The strategic acquisition (approximately $16.0 million) will integrate OTTR's EMR-integrated transplant management tools with CareDx's transplant diagnostics to streamline ordering and patient surveillance.

Related Acquisition Pages

Selling a company? Get in front of buyers like CareDx

Turn tracked acquisition activity into an outreach-ready buyer list.